Selective H3 receptor (H3R) blockade:: broad efficacy in cognition and schizophrenia

被引：14

作者：

Fox, GB

Esbenshade, TA

Pan, JB

Browman, KE

Zhang, M

Ballard, ME

Radek, RJ

Miner, H

Bitner, RS

Krueger, KM

Yao, BB

Faghih, R

Rueter, LE

Komater, VA

Drescher, KU

Buckley, MJ

Sullivan, JP

Cowart, MD

Decker, MW

Hancock, AA

机构：

[1] Abbott Labs, Abbott Pk, IL 60064 USA

[2] Abbott GmbH & Co KG, Global Pharmaceut Res Div, Neurosci Res, D-67061 Ludwigshafen, Germany

来源：

INFLAMMATION RESEARCH | 2005年 / 54卷 / Suppl 1期

关键词：

D O I：

10.1007/s00011-004-0410-1

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：S23 / S24

页数：2

共 7 条

[1]

Bentham P, 2004, LANCET, V363, P2105

[2] Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan [J].

Browman, KE ;

Komater, VA ;

Curzon, P ;

Rueter, LE ;

Hancock, AA ;

Decker, MW ;

Fox, GB .

BEHAVIOURAL BRAIN RESEARCH, 2004, 153 (01) :69-76

[3] Identification of novel H3 receptor (H3R) antagonists with cognition enhancing properties in rats [J].

Fox, GB ;

Pan, JB ;

Faghih, R ;

Esbenshade, TA ;

Lewis, A ;

Bitner, RS ;

Black, LA ;

Bennani, YL ;

Decker, MW ;

Hancock, AA .

INFLAMMATION RESEARCH, 2003, 52 (Suppl 1) :S31-S32

[4] Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920:: II.: In vivo behavioral and neurophysiological characterization [J].

Fox, GB ;

Pan, JB ;

Radek, RJ ;

Lewis, AM ;

Bitner, RS ;

Esbenshade, TA ;

Faghih, R ;

Bennani, YL ;

Williams, M ;

Yao, BB ;

Decker, MW ;

Hancock, AA .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :897-908

[5] Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects [J].

Geyer, MA ;

Tamminga, CA .

PSYCHOPHARMACOLOGY, 2004, 174 (01) :1-2

[6] Perspectives on cognitive domains, H3 receptor ligands and neurological disease [J].

Hancock, AA ;

Fox, GB .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (10) :1237-1248

[7] Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system [J].

Witkin, JM ;

Nelson, DL .

PHARMACOLOGY & THERAPEUTICS, 2004, 103 (01) :1-20

← 1 →